Matches in Nanopublications for { ?s ?p "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP789655.RAhoS3oPTOu7dJG6T31sNYEQj6bY_M5KVdgKcmpn1p3u4130_assertion description "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789655.RAhoS3oPTOu7dJG6T31sNYEQj6bY_M5KVdgKcmpn1p3u4130_provenance.
- NP842929.RAdh-8jzT_xB5xAmgCdoTjkIxddgtmpr_zA-9c0jqRvJQ130_assertion description "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842929.RAdh-8jzT_xB5xAmgCdoTjkIxddgtmpr_zA-9c0jqRvJQ130_provenance.
- NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_assertion description "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_provenance.
- NP440555.RAHfnr9oKJZKdj8_623P-DNwOTTTUpYF-BOsEos1KnecU130_assertion description "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440555.RAHfnr9oKJZKdj8_623P-DNwOTTTUpYF-BOsEos1KnecU130_provenance.
- NP437393.RA0Xu01B_MGqtCIDGZ9m_T8R4zUfcSd0o14WDinvYiEYQ130_assertion description "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437393.RA0Xu01B_MGqtCIDGZ9m_T8R4zUfcSd0o14WDinvYiEYQ130_provenance.
- NP762263.RAb5xsikaE9EXoE7q1qXSGOUfPEAn_CBKZDIIpxhyjAGU130_assertion description "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP762263.RAb5xsikaE9EXoE7q1qXSGOUfPEAn_CBKZDIIpxhyjAGU130_provenance.
- assertion description "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP779190.RAYg50waoXBGEPqCfiQ45Rqj9qhpcUpxKN1Lzyu5hRjTc130_assertion description "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779190.RAYg50waoXBGEPqCfiQ45Rqj9qhpcUpxKN1Lzyu5hRjTc130_provenance.
- NP762458.RADlvzTxM5yp2g6rqaCCE6WMCTkoFVm-6kJgwat3RiNFk130_assertion description "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP762458.RADlvzTxM5yp2g6rqaCCE6WMCTkoFVm-6kJgwat3RiNFk130_provenance.
- NP779187.RALtNhQjgGJYDGug44etoxwFnEr6J1jbUSj04FxK2KOTg130_assertion description "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779187.RALtNhQjgGJYDGug44etoxwFnEr6J1jbUSj04FxK2KOTg130_provenance.